These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 25372211)

  • 1. Retinal blood flow levels measured by laser speckle flowgraphy in patients who received intravitreal bevacizumab injection for macular edema secondary to central retinal vein occlusion.
    Matsumoto M; Suzuma K; Fukazawa Y; Yamada Y; Tsuiki E; Fujikawa A; Kitaoka T
    Retin Cases Brief Rep; 2014; 8(1):60-6. PubMed ID: 25372211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in retinal blood flow in patients with macular edema secondary to branch retinal vein occlusion before and after intravitreal injection of bevacizumab.
    Nagaoka T; Sogawa K; Yoshida A
    Retina; 2014 Oct; 34(10):2037-43. PubMed ID: 24896136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series.
    Noma H; Yasuda K; Minezaki T; Watarai S; Shimura M
    BMC Ophthalmol; 2016 May; 16():61. PubMed ID: 27225268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RETINAL BLOOD FLOW AFTER INTRAVITREAL BEVACIZUMAB IS A PREDICTIVE FACTOR FOR OUTCOMES OF MACULAR EDEMA ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION.
    Matsumoto M; Suzuma K; Yamada Y; Tsuiki E; Fujikawa A; Kitaoka T
    Retina; 2018 Feb; 38(2):283-291. PubMed ID: 28151838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Retinal Microcirculation After Intravitreal Ranibizumab Injection in Eyes With Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Fukami M; Iwase T; Yamamoto K; Kaneko H; Yasuda S; Terasaki H
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1246-1255. PubMed ID: 28241312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion.
    Gokce G; Sobaci G; Durukan AH; Erdurman FC
    Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal bevacizumab for treatment of macular edema secondary to central retinal vein occlusion: eighteen-month results of a prospective trial.
    Zhang H; Liu ZL; Sun P; Gu F
    J Ocul Pharmacol Ther; 2011 Dec; 27(6):615-21. PubMed ID: 21823986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
    Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
    BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusion persisting despite multiple intravitreal bevacizumab injections.
    Alshareef RA; Garg SJ; Hsu J; Vander J; Park C; Spirn MJ
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):512-6. PubMed ID: 24828198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a single intravitreal bevacizumab injection on contrast sensitivity and macular thickness in eyes with macular edema from central retinal vein occlusion: a prospective, nonrandomized, three-month follow-up study.
    Preti RC; Ramirez LM; Pimentel SL; Nakashima Y; Machado CG; Pelayes DE; Monteiro ML; Takahashi WY
    Ophthalmic Res; 2014; 51(3):140-5. PubMed ID: 24525617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion.
    Higashiyama T; Sawada O; Kakinoki M; Sawada T; Kawamura H; Ohji M
    Acta Ophthalmol; 2013 Jun; 91(4):318-24. PubMed ID: 22132711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
    Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
    Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Ocular Blood Flow after Ranibizumab Intravitreal Injection for Diabetic Macular Edema Measured Using Laser Speckle Flowgraphy.
    Toto L; Evangelista F; Viggiano P; Erroi E; D'Onofrio G; Libertini D; Porreca A; D'Aloisio R; Mariacristina P; Di Antonio L; Di Nicola M; Mastropasqua R
    Biomed Res Int; 2020; 2020():9496242. PubMed ID: 32104710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for macular edema due to central retinal vein occlusion: perfused vs. ischemic and early vs. late treatment.
    DeCroos FC; Ehlers JP; Stinnett S; Fekrat S
    Curr Eye Res; 2011 Dec; 36(12):1164-70. PubMed ID: 21978179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medium-term effects of intravitreal bevacizumab for macular edema associated with central retinal vein occlusion].
    Ono A; Fukuda K; Yamashita A; Shiragami C; Yamaji H; Shiraga F
    Nippon Ganka Gakkai Zasshi; 2011 Apr; 115(4):382-5. PubMed ID: 21598607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.
    Prager F; Michels S; Kriechbaum K; Georgopoulos M; Funk M; Geitzenauer W; Polak K; Schmidt-Erfurth U
    Br J Ophthalmol; 2009 Apr; 93(4):452-6. PubMed ID: 19074916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Blood Flow as a Predictor of Recurrence of Macular Edema after Intravitreal Ranibizumab Injection in Central Retinal Vein Occlusion.
    Takano Y; Noma H; Yasuda K; Yamaguchi T; Goto H; Shimura M
    Ophthalmic Res; 2021; 64(6):1013-1019. PubMed ID: 34461615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
    Pai SA; Shetty R; Vijayan PB; Venkatasubramaniam G; Yadav NK; Shetty BK; Babu RB; Narayana KM
    Am J Ophthalmol; 2007 Apr; 143(4):601-6. PubMed ID: 17306753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal ranibizumab for macular oedema secondary to retinal vein occlusion: a retrospective study of 34 eyes.
    Puche N; Glacet A; Mimoun G; Zourdani A; Coscas G; Soubrane G
    Acta Ophthalmol; 2012 Jun; 90(4):357-61. PubMed ID: 20602625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.